ArticleEndocrine2025
Estimated glucose disposal rate (eGDR) and prehypertension in Non-Diabetic Japanese adults: A secondary analysis of the NAGALA Cross-Sectional study.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThe association between estimated glucose disposal rate (eGDR) and prehypertension (pre-HTN) in non-diabetic Japanese adults was investigated in our study.
methodsData from 15,464 participants aged 18–79 years in the NAGALA-based study (2004–2015) were further analyzed. A total of 14,170 non-diabetic individuals were included to explore the association between eGDR—calculated using two established formulas, one based on waist circumference (WC) and the other on body mass index (BMI)—and pre-HTN. Multivariable logistic regression adjusted for serum biomarkers and clinical characteristics was used to evaluate the relationship. Both stratified analysis and Bayesian network (BN) models have been employed to further substantiate this relationship.
results30.1% of pre-HTN were shown in the enrolled patients (4,266/14,170). After adjusting for confounders, lower eGDR levels were significantly associated with higher pre-HTN risk. The adjusted odds ratio for the first tertile of eGDR.WC and eGDR.BMI, compared to the highest tertile, were 3.36 (95%CI: 2.99–3.77) and 3.39 (95%CI: 3.04–3.78) respectively. An increase of 1-unit in eGDR was found to link with a 52% reduction in the prevalence of pre-HTN for eGDR.WC (adjusted OR = 0.48, 95%CI: 0.45–0.51) and a 60% reduction for eGDR.BMI (adjusted OR = 0.40, 95%CI: 0.38–0.43). Stratified analysis confirmed a negative correlation between eGDR and pre-HTN across subgroups, which was also corroborated in BN models.
conclusionsIn non-diabetic Japanese adults, lower eGDR levels were significantly associated with higher pre-HTN prevalence, suggesting eGDR as a potential indicator for hypertension prevention and deserving more clinical research’s validation.
Indexed as
Identifiers
41461903What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.